ArticleFrontiers in pharmacology2025
Localization of the therapeutic targets for endothelin receptor antagonists and sodium-glucose co-transporter 2 inhibitors in the chronic liver disease, primary sclerosing cholangitis.
Rhoda E Kuc et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.